Seattle-based Calypso Medical Technologies announced today it has signed a strategic development agreement with Siemens Healthcare to jointly develop products for radiation therapy of pancreas and lung cancer, as well as prostate cancer. Financial details weren’t given. Calypso makes tracking technologies that help deliver pinpoint radiation to tumors. The company raised $50 million in September, and also has partnerships with Varian Medical Systems, Elekta, and Philips Medical.
via seattlepi.com
Posted via web from Avantrasara
You must log in to post a comment.
{ 1 trackback }